When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves' disease be discontinued?
Suyeon ParkEyun SongHye-Seon OhMijin KimMin Ji JeonWon Gu KimTae Yong KimYoung Kee ShongDoo Man KimWon Bae KimPublished in: Endocrine (2019)
An MMDT longer than 6 months and a high T3/fT4 ratio at ATD withdrawal were independent predictors of relapse in patients who achieved initial remission after ATD for GD. These factors could be used to determine the optimal time to withdraw ATD during the treatment of GD hyperthyroidism.